Drug refractory faciobrachial dystonic seizures successfully treated with multiple apheresis
Abstract
Faciobrachial dystonic epileptic seizures usually precede the cognitive impairment associated with non-paraneoplastic limbic encephalitis secondary to voltage gated potassium channel complex (VGKC) antibodies, specifically to leucine-rich glioma inactivated 1 (LGI1) antibodies. Testing for VGKC-complex/LGI1 antibodies should be initiated with the recognition of faciobrachial dystonic seizures. This seizure subtype is refractory to treatment with the anti-epileptic drugs, but has been shown to be immunotherapy responsive. Early initiation of immunotherapy has been shown to fasten the time to recovery and also in minimizing the cognitive impairment.
Full Text:
PDFDOI: https://doi.org/10.5430/crim.v3n3p69
Refbacks
- There are currently no refbacks.
Case Reports in Internal Medicine
ISSN 2332-7243(Print) ISSN 2332-7251(Online)
Copyright © Sciedu Press
To make sure that you can receive messages from us, please add the ‘sciedupress.com’ domains to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', please check your 'spam' or 'junk' folder.